Compositions and methods for treating or preventing inflammatory diseases
Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.
1 .- 45 . (canceled)
46 . A medical device comprising an anti-microtubule agent, wherein the medical device is a plastic surgery implant, cardiovascular device, neurological or neurosurgical device, cardiovascular device, genitourinary device, ophthalmologic implant, otolaryngology device, or orthopedic implant.
47 . The medical device of claim 46 , wherein the anti-microtubule agent is selected from camptothecin, eleutherobin, sarcodictyins, epothilones A and B, discodermolide, deuterium oxide (D 2 O), hexylene glycol (2-methyl-2,4-pentanediol), tubercidin (7-deazaadenosine), LY290181 (2-amino-4-(3-pyridyl)-4H-naphtho(1,2-b)pyran-3-cardonitrile), aluminum fluoride, ethylene glycol bis-(succinimidylsuccinate), glycine ethyl ester, and analogues and derivatives of any of the above agents.
48 . The medical device of claim 46 , wherein the anti-microtubule agent is a taxane.
49 . The medical device of claim 48 , wherein the taxane is paclitaxel.
50 . The medical device of claim 46 , wherein the anti-microtubule agent is a derivative or analogue of paclitaxel.
51 . The medical device of claim 46 , wherein the medical device is a plastic surgery implant.
52 . The medical device of claim 51 , wherein the plastic surgery implant is an implant for preventing fibrous contracture or a chin implant.
53 . The medical device of claim 46 , wherein the medical device is a neurological or neurosurgical device.
54 . The medical device of claim 53 , wherein the medical device is a ventricular peritoneal shunt, a ventricular atrial shunt, a nerve stimulator device, a dural patch or implant, or a device for continuous subarachnoid infusion.
55 . The medical device of claim 46 , wherein the medical device is a cardiovascular device.
56 . The medical device of claim 55 , wherein the cardiovascular device is a venous catheter, a venous port, a tunneled venous catheter, a chronic infusion line or port, a hepatic artery infusion catheter, a pacemaker wire, or a defibrillator.
57 . The medical device of claim 46 , wherein the medical device is a gastrointestinal device.
58 . The medical device of claim 57 , wherein the gastrointestinal device is a chronic indwelling catheter, a feeding tube, a portosystemic shunt, a shunt for ascites, a peritoneal implant for drug delivery, a peritoneal dialysis catheter, an implantable mesh for hernias, or an implant for preventing surgical adhesion.
59 . The medical device of claim 46 , wherein the medical device is a genitourinary device.
60 . The medical device of claim 59 , wherein the genitourinary device is a uterine implant, a fallopian tubal implant, an artificial sphincter, a periuretharal implant for incontinence, a chronic indwelling catheter, a bladder augmentation, or a wrap or splint for vasovasostomy.
61 . The medical device of claim 46 , wherein the medical device is an ophthalmologic implant.
62 . The medical device of claim 61 , wherein the ophthalmologic implant is a multino implant or another implant for neovascular glaucoma, drug eluting contact lenses for pterygium, a splint for failed dacrocystalrhinostomy, drug eluting contact lenses for corneal neovascularity, an implant for diabetic retinopathy, or drug eluting contact lenses for high risk corneal transplants.
63 . The medical device of claim 46 , wherein the medical device is an otolaryngology device.
64 . The medical device of claim 63 , wherein the otolaryngology device is an ossicular implant, a Eustachian tube splint for glue ear or chronic otitis.
65 . The medical device of claim 46 , wherein the medical device is an orthopedic implant.
66 . The medical device of claim 65 , wherein the orthopedic implant is a cemented orthopedic prosthesis.
67 . The medical device of claim 46 , further comprising a polymeric carrier of the anti-microtubule agent.
68 . The medical device of claim 67 , wherein the polymeric carrier is selected from the group consisting of poly(ethylene-vinyl acetate), poly(D,L-lactic acid) oligomers and polymers, poly(L-lactic acid) oligomers and polymers, poly(glycolic acid), copolymers of lactic acid and glycolic acid, poly(caprolactone), poly(valerolactone), polyanhydrides, copolymers of poly(caprolactone) or poly(lactic acid) with a polyethylene glycol (e.g., MePEG), and blends thereof.
69 . The medical device of claim 67 , wherein the polymeric carrier is selected from albumin, collagen, gelatin, hyaluronic acid, starch, cellulose, casein, dextrans, polysaccharides, fibrinogen, poly(D,L-lactide), poly(D,L-lactide-co-glycolide), poly(glycolide), poly(hydroxybutyrate), poly(alkylcarbonate) and poly(orthoesters), polyesters, poly(hydroxyvaleric acid), polydioxanone, poly(ethylene terephthalate), poly(malic acid), poly(tartronic acid), polyanhydrides, polyphosphazenes, poly(amino acids) and their copolymers.
70 . The medical device of claim 67 , wherein the polymeric carrier is selected from the group consisting of poly(ethylene-vinyl acetate) copolymers, silicone rubber, acrylic polymers, polyethylene, polypropylene, polyamides, polyurethane, poly(ester urethanes), poly(ether urethanes), poly(ester-urea), polyethers, poly(ethylene oxide), poly(propylene oxide), Pluronics and poly(tetramethylene glycol)), silicone rubbers, vinyl polymers, alginate, carrageenin, carboxymethyl cellulose, poly(acrylic acid), chitosan, poly-L-lysine, polyethylenimine, and poly(allyl amine).